Holista Colltech (ASX:HCT) application to advertise effectiveness in killing Covid 19 - Sequoia Direct Pty Ltd

27NovNovember 27, 2020

Holista Colltech (ASX:HCT) application to advertise effectiveness in killing Covid 19

Natural wellness company, Holista Colltech (ASX:HCT) has commissioned an application to allow its NatShieldTM and ProtecteneTM range of products to be labelled as effective in killing the Covid 19 virus.

The application to the Therapeutic Goods Administration is being made by a third-party consulting firm and may also allow the products to be categorised as “Therapeutic Goods”.

The NatShieldTM hand sanitiser and wipes can currently claim to be antibacterial and 99.99 per cent effective in killing germs. It’s currently sold in Australia as “cosmetic goods”.

However, cosmetic products can only be used on the skin, while therapeutic goods can claim to treat a disease or its symptoms.

Additional testing is planned to measure the effectiveness against airborne viruses by using a fogging delivery system in public thoroughfares.

Shares in Holista Colltech (ASX:HCT) are trading 2.99 per cent higher at 7 cents.

Copyright 2020 – Finance News Network

Source: Finance News Network

Related Posts

25JanJanuary 25, 2021

Ampol (ASX:ALD) successfully completes $300 million off-market share buy-back

25 Jan 2021 - Ampol (ASX:ALD) has successfully completed a $300 million off-market share buy-back.

05SepSeptember 5, 2022

Stocks of the Hour: Great Boulder Resources, Kingwest Resources, Tamboran Resources

05 Sep 2022 - A snapshot of the stocks on the move featuring Great Boulder Resources (ASX:GBR), Kingwest Resources (ASX:KWR) and Tamboran Resources (ASX:TBN).

23SepSeptember 23, 2019

ANZ finalises sale of PNG Retail, Commercial and SME businesses to Kina Bank

23 Sep 2019 - ANZ has today announced the completion of the sale of its retail, commercial and small-medium sized enterprise businesses in Papua New Guinea to Kina Bank.

13FebFebruary 13, 2020

Pro Medicus (ASX:PME) see strong profit growth

13 Feb 2020 - Pro Medicus (ASX:PME) released their results for the six months ending December 31, showing after tax profit of $12.051 million, an increase of $2.969 million up 32.7 per cent compared to the same period last year.

20JanJanuary 20, 2020

G Medical Innovations (ASX:GMV) secured Taiwan FDA approval

20 Jan 2020 - Medical product provider, G Medical Innovations (ASX:GMV) has secured regulatory approval from the Taiwan Food and Drug Administration for its Prizma device.

17MarMarch 17, 2021

Red 5 (ASX:RED) raises $175 million of debt finance

17 Mar 2021 - Red 5 (ASX:RED) has received commitments for $175 million in project finance facilities to fund the development of its 2.4 million ounces, 16-year Life-Of-Mine King of the Hills Project in Western Australia.

23AprApril 23, 2020

Electro Optic Systems (ASX:EOS) awarded NATO navies contract

23 Apr 2020 - Electro Optic Systems (ASX:EOS) Brisbane-based subsidiary, EM Solutions, has won $14 million of orders from four navies for its Cobra maritime satellite terminals.

14AugAugust 14, 2020

Iluka Resources (ASX:ILU) NPAT drops 17% in second half

14 Aug 2020 - Iluka Resources (ASX:ILU) today announced its 2020 half year results for the period ended 30 June 2020.

09JanJanuary 9, 2020

Lake Resources (ASX:LKE) produce 99.9% purity lithium carbonate

09 Jan 2020 - Lithium explorer and developer Lake Resources (ASX:LKE) has confirmed that battery grade lithium carbonate with 99.9 per cent purity has been produced with very low impurities from Lake’s Kachi Lithium Brine Project.

08NovNovember 8, 2019

The REA Group (ASX:REA) report a 14% drop in EBITDA for the first quarter

08 Nov 2019 - Online real estate classifieds company the REA Group (ASX:REA) reported a 14 per cent drop in earnings before interest, tax, depreciation and amortisation (EBITDA) to $114.9 million for the first quarter ending September. 30th.